Treatment for osteonecrosis of femoral head by hVEGF-165 gene modified marrow stromal stem cells under arthroscope

National Medical Journal of China

Volumn 89, Issue 37, 2009, Pages 2629-2633

  Liu, Bao Yi ^a   Zhao, De Wei ^a  

^a DALIAN UNIVERSITY   (China)

Author keywords

Arthroscope; Femur head necrosis; Hematopoietic stem cells transplatation

Indexed keywords

VASCULOTROPIN A;

ANIMAL; ARTHROSCOPY; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CYTOLOGY; FEMALE; FEMUR HEAD NECROSIS; GENETIC TRANSFECTION; GENETICS; MALE; METHODOLOGY; RABBIT; STROMA CELL; TISSUE ENGINEERING;

ANIMALS; ARTHROSCOPY; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; FEMALE; FEMUR HEAD NECROSIS; MALE; RABBITS; STROMAL CELLS; TISSUE ENGINEERING; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84871456160     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2009.37.010     Document Type: Article

References (11)

1. Tarte K, Monnier D, Tribut O, et al. Influence of inflammatory factors produced during Graft-Versus-Host disease on immunological properties of mesenchymal stem cells (MSC). Blood, 2006, 108: 32-41.
2. 2006, 86: 1489-1492.
3. Feng L, Guo M, Zhang S, et al. Optimization of transfection mediated by calcium phosphate for plasmid rAAV-LacZ (recombinant adeno-associated virus-beta-galactosidase reporter gene) production in suspension-cultured HEK-293 (human embryonic kidney 293) cells. Biotechnol Appl Biochem, 2007, 46: 127-135.
4. Wu X, Rabkin Aikawa E, Guleserian KJ, et al. Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. Am J Physiol Heart Circ Physiol, 2004, 287: 480-487.
5. Murphy WL, Peters MC, Kohn DH, et al. Sustained release of vascular endothelial growth factor from mineralized poly (lactide-co-gly-colide) scaffolds for tissue engineering. Biomaterials, 2000, 21: 2521-2527.
6. Murphy WL, Simmons CA, Kaigler D, et al. Bone regeneration via a mineral substrate and induced angiogenesis. J Dent Res, 2004, 83: 204-210.
7. Chang CS, Su CY, Lin TC. Scanning electron microscopy observation of vascularization around hydroxyapatite using vascular corrosioncasts. J BiomedMater Res, 1999, 48: 411-416.
8. Lu Y, Shansky J, Del Tatto M, et al. Recombinant vascular endothelial growth factor secreted from tissue-engineered bioartificial musclesp romotes localized angiogenesis. Circulation, 2001, 104: 594-599.
9. Lee MH, Kim YJ, Kim HJ, et al. VEGF-165-induced runx2 expression is mediated by Dlx5, and TGF-1 opposes the VEGF-165-induced osteoblast differentiation by suppression of Dlx5 expression. Biol Chem, 2003, 278: 34387-34394.
10. Cui Q, Azer NM, Saleh KJ, et al. Use of genetically engineered bone marrow stem cells to treat osteonecrosis: an experiment study. J Bone Joint Surg Br Proceedings, 2006, 88: 306.
11. Stone BJ, Yoo JU. Autologous mesenchymal progenitor cells in articular cartilage repair. Clin Orthop, 1999, 376: 156-162.